Form 4 for INSM INSMED Inc
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001628280-25-026581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-19 | 2025-05-15+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $65.79 | -11.7K | 84.8K | -12% | -$771.3K |
| D | 2025-05-19 | 2025-05-15 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | $0.00 | +6,508 | 96.5K | +7% | $0 |
| D | 2025-05-19 | 2025-05-15 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | $0.00 | +31.6K | 31.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | S | D | 9,925 | $65.47 | 86,596 | D | — | — | (F4) This is the weighted average sales price representing 9,925 shares sold at prices ranging from $65.32 to $65.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2025-05-16 | S | D | 1,799 | $67.53 | 84,797 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-15 | A | A | 6,508 | $0.00 | 96,521 | D | — | — | (F1) Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. (F2) Each RSU was granted on May 15, 2025 for no consideration. |
| 4 | Derivative | Stock Option (right to buy) | 2025-05-15 | A | A | 31,610 | $0.00 | 31,610 | D | $67.22 · — to 2035-05-15 | 31,610 Common Stock | (F5) These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |